Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Plos One|February 25, 2016
NADPH Oxidase 1 Is Associated with Altered Host Survival and T Cell Phenotypes after Influenza A Virus Infection in MiceAmelia R Hofstetter, Juan A De La Cruz, Weiping Cao, et al.The Journal of Infectious Diseases|May 3, 2019
Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV InfectionSamuel Amoah, Margarita Mishina, Prabda Praphasiri, et al.NPJ Vaccines|February 17, 2021
Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adultsAthena P Y Li, Carolyn A Cohen, Nancy H L Leung, et al.Nature Communications|January 4, 2024
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccinesFeng Liu, F Liaini Gross, Sneha Joshi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label TrialManjusha Gaglani, Sara S Kim, Allison L Naleway, et al.Open Forum Infectious Diseases|June 12, 2023
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020Allison L Naleway, Sara S Kim, Brendan Flannery, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2021
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label TrialFatimah S Dawood, Allison L Naleway, Brendan Flannery, et al.Journal of Virology|July 31, 2024
The frequency and function of nucleoprotein-specific CD8+ T cells are critical for heterosubtypic immunity against influenza virus infectionSamuel Amoah, Weiping Cao, Ekramy E Sayedahmed, et al.Vaccine|June 20, 2025
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnelMargarita Mishina, Weiping Cao, Zachary Ende, et al.Journal of Virology|August 4, 2025
Trained ILCs confer adaptive immunity-independent protection against influenzaWadzanai P Mboko, Yuanyuan Wang, Weiping Cao, et al.Pageof 7